A retrospective comparison of BU-fludarabine and BU–CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT

Abstract

Allogeneic hematopoietic SCT (allo-HSCT) is an effective treatment for haematological malignancies. As only about 30% of patients have a matched sibling donor or matched unrelated donor, transplantation from a related haploidentical donor is an effective option. There are several kinds of protocols for haploidential transplantation. In our institution, we… (More)
DOI: 10.1038/bmt.2014.303

Topics

2 Figures and Tables

Cite this paper

@article{Sun2015ARC, title={A retrospective comparison of BU-fludarabine and BU–CY regimens in elderly patients or in patients with comorbidities who received unmanipulated haploidentical hematopoietic SCT}, author={Y. Q. Sun and L. T. Xu and Xin-Hua Zhang and D-h Liu and H. Chen and Yuyu Wang and C-h Yan and J-z Wang and F-r Wang and Y-y Zhang and K. S. Liu and X. G. Huang}, journal={Bone Marrow Transplantation}, year={2015}, volume={50}, pages={601-603} }